Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Subscribe to see Sift Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sift Biosciences, Inc. is a biotechnology company headquartered in San Carlos, United States. Its most recent funding round, Pre-Seed, raised $3.7M in February 2026. Xcout tracks 8 named people at Sift Biosciences, Inc., including Yue Lou (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for Sift Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $3.7M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Sift Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Enara Bio is a biotechnology company headquartered in Oxford, Oxfordshire, backed by prominent life science investors. The company focuses on advancing cancer immunotherapy by targeting novel Dark Antigen assets.
Variant Bio is a privately held biotechnology company founded in 2018 and headquartered in Seattle, Washington. The company aims to develop life-saving therapeutics by studying the genetic variations of human populations with exceptional health-related traits.
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Sift Biosciences, Inc.? Suggest a correction · Work at Sift Biosciences, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.